
ARHGAP20 Expression Inhibited HCC Progression by Regulating the PI3K-AKT Signaling Pathway
Author(s) -
Gao-Min Liu,
Jia Li,
Caiyun Zhang,
Dongyang Huang,
Jiachao Xu
Publication year - 2021
Publication title -
journal of hepatocellular carcinoma
Language(s) - English
Resource type - Journals
ISSN - 2253-5969
DOI - 10.2147/jhc.s298554
Subject(s) - pi3k/akt/mtor pathway , protein kinase b , cancer research , signal transduction , tumor microenvironment , downregulation and upregulation , metastasis , hepatocellular carcinoma , biology , tumor progression , medicine , cancer , immunology , gene , microbiology and biotechnology , biochemistry , tumor cells
One of the most common cancers is hepatocellular carcinoma (HCC), which is an aggressive cancer that is associated with high mortality. The expression and role of ARHGAP20 in HCC remain unclear.